KCRS21

Article

On October 7-8, 2021, KidneyCAN hosted the third annual Kidney Cancer Research Summit in Philadelphia, Pennsylvania.

On October 7-8, 2021, KidneyCAN hosted the third annual Kidney Cancer Research Summit in Philadelphia, Pennsylvania. You can see the KCRS21 program highlights, view all presentation video and slides, and learn more at https://kcrs.kidneycan.org/.

Related Videos
Dr. Ged in an interview with CURE at the 2023 KCRS
Dr. Toni Choueiri in an interview with CURE at the 2023 KCRS
Dr. Hannan in an interview with CURE at the KCRS conference
Related Content
Image of a patient receiving radiation therapy.

What Patients With Kidney Cancer Need to Know About Radiation Therapy

March 29th 2024
Article

An expert explains what patients need to keep in mind and what conversations they should be having with their care teams.

Read More

kidneys

Research Continues for Best Immunotherapy Order in Advanced RCC

July 21st 2023
Article

Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.

Read More

image of clear cell renal cell carcinoma

How Cancer Teams Leverage Biology in Guiding First-Line Therapy for Clear Cell RCC

July 19th 2023
Article

An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.

Read More

Kidneys reflecting off of an iPad tablet

BAP1-Mutated RCC Responds to Treatment with Lynparza

July 18th 2023
Article

Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.

Read More

stethoscope, vial, and pills

New Drugs Being Explored in Kidney Cancer

July 17th 2023
Article

An expert gives an overview of up-and-coming treatments for patients with kidney cancer.

Read More

colorful kidneys

Drug Duo Continues to Show Promise in Advanced Kidney Cancer

July 16th 2023
Article

Long-term follow-up data showed that Lenvima plus Keytruda continued to show benefit in patients with metastatic kidney cancer.

Read More